Nurix Therapeutics, Inc. (NRIX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.47B |
| Enterprise Value | 1.27B |
| P/E Ratio | 10.16 |
| PEG Ratio | 0.08 |
| Price/Sales Ratio | 3.97 |
| Price/Book Ratio | 2.94 |
| Enterprise/Revenue | 3.04 |
| Enterprise/EBITDA | 6.61 |
Fiscal Year
| Fiscal Year | November 30, 2025 |
| Most Recent Quarter | August 31, 2026 |
Profitability
| Profit Margin | 0.42 |
| Operating Margin | 0.41 |
AD
Management Effectiveness
| Return On Assets | 0.25 |
| Return On Equity | 0.49 |
Income Statement
| Revenue | 83.98M |
| Revenue/Share | 6.29 |
| Gross Profit | 65.12M |
| EBITDA | -244.84M |
| Net Income | -264.46M |
| Diluted EPS | -3.05 |
Balance Sheet
| Total Cash | 1.05B |
| Total Cash/Share | 9.4 |
| Total Debt | 65.33M |
| Total Debt/Equity | 0.07 |
| Current Ratio | 8.44 |
| Book Value Per Share | 8.68 |
Price History
| 52-Week Change | 139.98 |
| 52-Week High | 28.23 |
| 52-Week Low | 10.28 |
| Moving Average 50 Days | 25.09 |
| Moving Average 200 Days | 19.91 |
Statistics
| Average Volume | 1.6M |
| Shares Outstanding | 109.25M |
| % Held by Institutions | 106.31 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
